RCE in Marvalglobal Marval Msm
CVE-2022-31885
Marval MSM v14.19.0.12476 is vulnerable to OS Command Injection due to the insecure handling of VBScripts.
Vulnerability class: Command Injection (OS Command Injection)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.328 (98.3th percentile), scored .
Moderate probability of exploitation in the next 30 days — watch for active exploitation reports. 98th percentile — 98.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.320 · newest: 0.328 · change: +0.008
Affected products
- Marvalglobal Marval Msm — versions 14.19.0.12476
Weakness classification (CWE)
Public proof-of-concept exploits
References
- marvalglobal.com/ (Product, Vendor Advisory)
- drive.google.com/drive/folders/1Qa-6-LUzEnduSGfWLUjVLCyKr5wuEu5k (Exploit, Third Party Advisory)
- cyber-guy.gitbook.io/cyber-guy/pocs/marval-msm/os-command-injection (Exploit, Third Party Advisory)
Frequently asked questions
- What is CVE-2022-31885?
- CVE-2022-31885 is a critical-severity vulnerability in Marvalglobal Marval Msm, classified under OS Command Injection. CVSS score: 9.8/10. Published 2022-06-28.
- How severe is CVE-2022-31885?
- Critical severity. CVSS v3 base score is 9.8 out of 10.
- Is CVE-2022-31885 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.